Share on StockTwits

Shares of IMS Health Holdings (NYSE:IMS) hit a new 52-week high during mid-day trading on Monday , AmericanBankingNews.com reports. The stock traded as high as $27.81 and last traded at $27.15, with a volume of 197,360 shares traded. The stock had previously closed at $26.96.

IMS has been the subject of a number of recent research reports. Analysts at Goldman Sachs raised their price target on shares of IMS Health Holdings from $25.00 to $26.00 in a research note on Tuesday, August 5th. Separately, analysts at Drexel Hamilton initiated coverage on shares of IMS Health Holdings in a research note on Tuesday, August 5th. They set a “buy” rating and a $30.00 price target on the stock. Finally, analysts at Mizuho raised their price target on shares of IMS Health Holdings from $29.00 to $31.00 in a research note on Thursday, July 24th. They now have a “buy” rating on the stock. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. IMS Health Holdings has a consensus rating of “Buy” and an average target price of $27.91.

The stock has a 50-day moving average of $26.25 and a 200-day moving average of $24.83. The company’s market cap is $9.087 billion.

IMS Health Holdings (NYSE:IMS) last announced its earnings results on Thursday, July 24th. The company reported $0.39 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.37 by $0.02. The company had revenue of $662.00 million for the quarter, compared to the consensus estimate of $654.92 million. IMS Health Holdings’s revenue was up 6.1% compared to the same quarter last year. Analysts expect that IMS Health Holdings will post $1.38 EPS for the current fiscal year.

IMS Health Holdings, Inc (NYSE:IMS) is a global information and technology services company providing solutions to the clients in the healthcare industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.